title: Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement.
authors.forename: Mirko
authors.initials: M
authors.lastname: Manetti
authors.forename: Serena
authors.initials: S
authors.lastname: Guiducci
authors.forename: Claudia
authors.initials: C
authors.lastname: Ceccarelli
authors.forename: Eloisa
authors.initials: E
authors.lastname: Romano
authors.forename: Silvia
authors.initials: S
authors.lastname: Bellando-Randone
authors.forename: Maria Letizia
authors.initials: ML
authors.lastname: Conforti
authors.forename: Lidia
authors.initials: L
authors.lastname: Ibba-Manneschi
authors.forename: Marco
authors.initials: M
authors.lastname: Matucci-Cerinic
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D000067596:Interleukin-33; D007378:Interleukins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000276:immunology*; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; C506536:IL33 protein, human; D000067596:Interleukin-33; D007378:Interleukins